HSBC Holdings
BPTH

HSBC Holdings’s Bio-Path Holdings Inc BPTH Stock Holding History

HSBC Holdings’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4
Closed -$21K – 2663
2016
Q4 		$21K Buy
+4
New +$19.4K ﹤0.01% 2699

Other funds holding BPTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RCA
Rowland Carmichael Advisors Scottsdale, Arizona $316M AUM 18.07% 1-Year Est. Return

HSBC Holdings's BPTH Position: Q1 2017 in Review

HSBC Holdings sold out of Bio-Path Holdings Inc (BPTH) in Q1 2017, closing a stake of 4 shares — an estimated $21K sold.

HSBC Holdings first reported a position in BPTH in Q4 2016 and held it in 1 quarter. The position peaked at $21K in Q4 2016. 43 funds tracked by Wall St. Rank hold BPTH as of Q1 2017.

  • HSBC Holdings reported no remaining Bio-Path Holdings Inc position as of Q1 2017 after selling out during the quarter.
  • HSBC Holdings sold 4 Bio-Path Holdings Inc shares in Q1 2017, an estimated $21K.
  • HSBC Holdings first reported a position in Bio-Path Holdings Inc in Q4 2016 and held it in 1 quarter.
  • HSBC Holdings's Bio-Path Holdings Inc position peaked at $21K in Q4 2016.
  • 43 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q1 2017.

Based on HSBC Holdings's 13F filing for Q1 2017, filed 15 May 2017.